Prolactin as a local growth promoter in patients with breast cancer: GCRI experience
- 30 September 2000
- journal article
- Published by Elsevier BV in European Journal of Surgical Oncology
- Vol. 26 (6), 540-547
- https://doi.org/10.1053/ejso.2000.0943
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Prolactin, Growth Factors, and Cell Growth*Published by Taylor & Francis Ltd ,2018
- Coexpression of Bcl-2, c-Myc, and p53 oncoproteins as prognostic discriminants in patients with colorectal carcinomaDiseases of the Colon & Rectum, 1997
- Node negative breast carcinoma: Hyperprolactinemia and/or overexpression of p53 as an independent predictor of poor prognosis compared to newer and established prognosticatorsJournal of Surgical Oncology, 1996
- Growth hormone and prolactin are paracrine growth and differentiation factors in the haemopoietic systemImmunology Today, 1993
- Estradiol increases prolactin synthesis and prolactin messenger ribonucleic acid in selected brain regions in the hypophysectomized female rat.Endocrinology, 1992
- The physiology of decidual prolactin and other decidual protein hormonesTrends in Endocrinology & Metabolism, 1992
- Growth Factors and CancerScience, 1991
- Plasma prolactin as an indicator of disease progression in advanced breast cancerCancer, 1990
- Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extractionAnalytical Biochemistry, 1987
- Histological Grading and Prognosis in Breast CancerBritish Journal of Cancer, 1957